Variant report
Variant | nsv5363 |
---|---|
Chromosome Location | chr6:78856154-78914208 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142326001 | chr6:78863014-78863015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559774193 | chr6:78863023-78863024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115903118 | chr6:78863076-78863077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552293365 | chr6:78863092-78863093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546062626 | chr6:78863116-78863117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115836976 | chr6:78863124-78863125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531370513 | chr6:78863183-78863184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370395362 | chr6:78863186-78863187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9361374 | chr6:78863193-78863194 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs568383753 | chr6:78863197-78863198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181551016 | chr6:78863216-78863217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9448301 | chr6:78863266-78863267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs146361101 | chr6:78863279-78863280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186529972 | chr6:78863299-78863300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556658543 | chr6:78863318-78863319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576346043 | chr6:78863335-78863336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75203178 | chr6:78863390-78863391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148310572 | chr6:78863415-78863416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542252538 | chr6:78863425-78863426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541177812 | chr6:78863445-78863446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6921668 | chr6:78863471-78863472 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs578151943 | chr6:78863516-78863517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112339848 | chr6:78863522-78863523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545561696 | chr6:78863526-78863527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74993824 | chr6:78863544-78863545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531180236 | chr6:78863554-78863555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189556262 | chr6:78863563-78863564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72888352 | chr6:78863569-78863570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6454046 | chr6:78863599-78863600 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs181822424 | chr6:78863647-78863648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570651955 | chr6:78863690-78863691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533189309 | chr6:78863712-78863713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549987419 | chr6:78863724-78863725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140492161 | chr6:78863737-78863738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73475056 | chr6:78863765-78863766 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs368126795 | chr6:78863768-78863769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10943520 | chr6:78863829-78863830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs186124740 | chr6:78863891-78863892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534975856 | chr6:78863903-78863904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9359320 | chr6:78863959-78863960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114787519 | chr6:78863965-78863966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371564263 | chr6:78863973-78863974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578093120 | chr6:78863985-78863986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544015608 | chr6:78864007-78864008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376709324 | chr6:78864099-78864100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9448302 | chr6:78864109-78864110 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs537500409 | chr6:78864111-78864112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570085326 | chr6:78864134-78864135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9352573 | chr6:78864165-78864166 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs9443527 | chr6:78864204-78864205 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:78863000-78867200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:78863400-78863800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr6:78863400-78864200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:78867000-78867400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:78867200-78867400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:78867400-78868600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:78869200-78869400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr6:78869400-78869600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:78891000-78891200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:78891000-78892000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr6:78891200-78891600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:78891600-78892000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:78892000-78892200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:78899000-78899400 | Enhancers | Fetal Intestine Large | intestine |
15 | chr6:78899400-78899600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr6:78901600-78902000 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
17 | chr6:78901600-78902200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:78901800-78902000 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr6:78901800-78902000 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr6:78901800-78902600 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
21 | chr6:78902000-78902400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
22 | chr6:78908600-78908800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
23 | chr6:78914200-78914800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |